Why is Hind.Bio Science falling/rising?

As of 25-Jun, Hindustan Bio Sciences Ltd is currently priced at 8.60, reflecting a slight increase of 0.02 (0.23%). The stock has recently experienced a trend reversal, gaining after five consecutive days of decline. Despite this uptick, it has underperformed its sector by 0.82%. In terms of returns, the stock has seen a 10.42% decline over the past week, while it has increased by 1.06% over the past month. Year-to-date, the stock is down 15.77%, contrasting with a 5.91% gain in the benchmark. However, over the long term, the stock has shown significant growth, with a 112.87% increase over three years and a remarkable 418.07% rise over five years. The delivery volume has also seen a notable increase of 67.62% against the five-day average, indicating rising investor participation.
In the broader market context, the Sensex has gained 1.61% over the past week and 1.27% over the past month, suggesting that the overall market is performing positively. This contrasts with Hindustan Bio Sciences Ltd's recent performance, which has been weaker in the short term. The stock's current price is higher than its 100-day moving average but lower than its 5-day, 20-day, 50-day, and 200-day moving averages, indicating mixed signals regarding its trend. The liquidity of the stock appears adequate for trading, as it is based on 2% of the five-day average traded value. Overall, while the stock has shown some signs of recovery, its recent underperformance relative to the benchmark and sector suggests ongoing challenges.